Maureen McMahon

7PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Colloid and surface chemistryCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 30, 2025
A Phase 2 Trial of Hydroxychloroquine in Individuals at Risk for Rheumatoid Arthritis.

Kevin D Deane, Christopher C Striebich, Marie L Feser

|Nov 08, 2024
Anti-retinal Autoantibodies in Hydroxychloroquine Eye Toxicity.

Samuel D Good, Grazyna Adamus, Michael B Gorin

|Feb 23, 2022
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.

Lisa Zhu, Manpreet Singh, Sonia Lele

|Feb 19, 2021
A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus.

Brian J Skaggs, Jennifer Grossman, Lori Sahakian

|Apr 02, 2020
Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression.

Emily Liang, Mihaela Taylor, Maureen McMahon

Pageof 2